Botox maker Allergan seeks to remove the ban on marketing off-label uses for pharmaceuticals.

According to two late stage trials, Botox, which is popular for smoothing out the wrinkles sold by Allergan Inc., effectively reduced the number of headache days for adults suffering from chronic migraines.

The U.S. Food and Drug Administration have approved an injectable eye implant as a treatment for the retinal disease macular edema.

Though there are speculations abound regarding a prospective sale of the Irvine, California-based cosmetic products-specific company Allergan Inc., the CEO David Pyott said in an interview that the company is itself looking for acquisitions!

The first drug that can enhance eyelash growth has got an approval by the FDA. The drug called Latisse will be manufactured and marketed by Allergan.

Latisse, a drug to promote longer, thicker, darker eyelashes got the recommendations of FDA advisory panel for approval. However the FDA panel also recommended further studies to assess Latisse's use in certain groups of patients, such as young patients and people who lost their eyelashes because of chemotherapy.